•
Sep 30, 2023

CME Group Q3 2023 Earnings Report

CME Group's financial performance for Q3 2023 was reported, showing growth in revenue and adjusted earnings per share.

Key Takeaways

CME Group reported a revenue of $1.3 billion and an operating income of $820 million for Q3 2023. Net income stood at $750 million, with diluted earnings per share at $2.06. On an adjusted basis, net income was $818 million, and diluted earnings per share reached $2.25.

CME Group achieved its ninth consecutive quarter of double-digit growth in adjusted earnings per share.

Revenue increased by 9% due to market participants using CME markets to mitigate business risks amid geopolitical uncertainty.

Interest rate volume increased by 6%, driven by an 18% rise in Treasury futures ADV.

Significant growth was seen across agricultural, energy, and options products.

Total Revenue
$1.34B
Previous year: $1.23B
+9.0%
EPS
$2.25
Previous year: $1.98
+13.6%
Average Daily Volume
22.3M
Previous year: 22.44M
-0.6%
Average Rate Per Contract
$0.707
Previous year: $0.631
+12.0%
Gross Profit
$1.13B
Previous year: $1.04B
+9.1%
Cash and Equivalents
$2.3B
Previous year: $2.13B
+8.0%
Free Cash Flow
$837M
Previous year: $634M
+32.0%
Total Assets
$126B
Previous year: $178B
-29.6%

CME Group

CME Group

CME Group Revenue by Segment

Forward Guidance

CME Group did not provide specific forward guidance in the provided document. The document contains forward-looking statements, but they are primarily cautionary regarding factors that might affect their performance.

Revenue & Expenses

Visualization of income flow from segment revenue to net income